NCT00432757View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2007

Study Completion Date

March 31, 2007

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Ketotifen with a Contact Lens (generic name not yet established)

Trial Locations (3)

Unknown

Los Angeles

Charlotte

Memphis

All Listed Sponsors
lead

Vistakon Pharmaceuticals

INDUSTRY

NCT00432757 - Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter